CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience

Background: SARS-CoV-2 infection increases the clinical risk and mortality of patients with chronic lymphocytic leukemia (CLL). Covid-19 vaccinations have the potential to protect individuals from severe infection, but little is known about the antibody response profile in these patients after vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavilia, Fabrizio, Pratesi, Federico, Baratè, Claudia, Benedetti, Edoardo, Guerri, Valentina, Sammuri, Paola, Migliorini, Paola, Galimberti, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acute Lymphoblastic Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489250/
http://dx.doi.org/10.1016/S2152-2650(22)01318-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489250/
http://dx.doi.org/10.1016/S2152-2650(22)01318-0

Ejemplares similares